<DOC>
	<DOCNO>NCT02544477</DOCNO>
	<brief_summary>The primary objective study evaluate effect early application nasal high flow oxygen therapy pulmonary lobectomy incidence postoperative hypoxemia .</brief_summary>
	<brief_title>High-flow Nasal Cannula Oxygen Versus Conventional Oxygen Therapy After Pulmonary Lobectomy</brief_title>
	<detailed_description>High-flow nasal cannula oxygen ( HFNC ) treatment show several clinical advantage compare conventional oxygen therapy . Currently , report described effect HFNC postoperative patient thoracic surgery . The primary objective study determine incidence postoperative hypoxemia ( define PaO2/FiO2 ratio &lt; 300 ) patient lung cancer pulmonary lobectomy . In postoperative period extubation , patient randomly assign either : 1. standard oxygen therapy group ( control group ) 2 . HFNC group ( study group ) . In control group , patient receive oxygen treatment mean conventional face mask , level fraction inspire oxygen ( FiO2 ) set maintain peripheral oxygen saturation ( SpO2 ) = 92 % - 98 % . Patients study group give HFNC treatment gas flow level = 50 L/min FiO2 set maintain peripheral oxygen saturation ( SpO2 ) = 92 % - 98 % . After 48 hour study entry , patient evaluate possible interruption oxygen treatment basis clinical condition .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Pulmonary Valve Insufficiency</mesh_term>
	<criteria>plan pulmonary lobectomy lung cancer age &lt; 18 year patient refusal body mass index â‰¥35 kg/m2 sleep apnea syndrome tracheostomy home oxygen therapy pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>